Yagi & Co., Ltd.: New Material “LAVATECH” Containing Lava from Mt. Fuji to Be Exhibited at Heimtextil 2025
Yagi & Co., Ltd. (TOKYO:7460) (https://www.yaginet.co.jp/en/index.html) will unveil LAVATECH for the first time at the Heimtextil Exhibition in Germany (an international trade fair for home textiles and contract textiles). LAVATECH, which boasts a high far-infrared effect, is made by using special technology to finely crush lava rock found in the ground around Mt. Fuji for weaving into fibers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250110677601/en/
Mt. Fuji (Photo: Business Wire)
About LAVATECH
Since ancient times, the lava rock formed beneath Mt. Fuji has been carefully protected from changes in surface temperature and weathering. LAVATECH is made by weaving this high-quality underground lava rock. We have achieved a high far-infrared effect by using a special technology to finely crush the lava rock that lies underground at Mt. Fuji for weaving into fibers. This brand of materials enables the creation of new products that address a wide range of health issues in areas such as sleep, beauty and sports through their blood circulation-promoting effects.
LAVATECH official website: https://lavatech.jp/
Details of exhibit at Heimtextil 2025
At this exhibition, we will be displaying products in the fields of SLEEP, SPORTS, BEAUTY, and HEALTH that incorporate LAVATECH, this new material made using lava rock from Mt. Fuji.
Future developments
The Yagi Group's VISION is to unlock the potential of textiles through innovation to realize a sustainable society. We engage in various activities, with the key words of sustainable and global representing the basic strategies of our medium-term management plan. Through the development of LAVATECH, we will work to achieve the following.
- Develop new functional materials and expand global sales
- Improve awareness by strengthening branding and promotions through various sales channels
- Engage in the wellness business to support healthier lifestyle habits, which is directly linked to our Group’s ESG strategy
Overview of Heimtextil 2025
Heimtextil is the world's largest international trade fair for home and contract textiles, attracting over 2,800 exhibitors from all over the world. The trends disseminated from Heimtextil serve as guidelines for interior design, home furnishings, the hotel industry, and beyond.
Date and time: Tuesday, January 14 to Friday, January 17, 2025 9:00 a.m. to 6:00 p.m. (until 5:00 p.m. on the last day)
Venue: Frankfurt International Exhibition Center, Germany
Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany
Official website: https://heimtextil.messefrankfurt.com/frankfurt/en.html
*Advance registration and ticket purchase are required for entry.
Contact for inquiries regarding LAVATECH and exhibition details
Yagi & Co., Ltd.
Staff in charge: Wataru Yoshida, Section 241, Business Dept. 1, Lifestyle Division
MAIL: lavatech@yaginet.jp
TEL: +81-6-6266-7380
View source version on businesswire.com: https://www.businesswire.com/news/home/20250110677601/en/
Contacts
For inquiries regarding this release:
Corporate Management/IR Group, Corporate Planning Department,
Yagi & Co., Ltd.
Public Relations staff: Motoki Kinebuchi
TEL: +81-3-3667-3057 / Email: kinebuchim@yaginet.jp
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lenovo Integrates AI and Robotics to Deliver Smarter Retail Solutions10.1.2025 16:00:00 EET | Press release
Lenovo today introduced three new retail solutions that combine the best of robotics and artificial intelligence technologies. Premiering at NRF 2025 in New York City, each solution has been field-tested and proven in commercial settings. Lenovo Retail Content Management Services enables retailers to create, schedule and display digital content across screens store-wide, streamlining multimedia content management and enabling real-time updates and targeted messaging to drive awareness, interest and incremental sales. The complete solution comprises all hardware and software needed, and can be deployed, maintained and managed across multiple locations globally. A leading food and beverage chain has deployed this content management service across 100+ stores and achieved substantial cost savings from dynamically managed promotional campaigns, reduced use of paper marketing materials, and reduced manpower needed to manage both campaigns and devices. Lenovo Retail Robotics with Yunji offer
Institute of Molecular and Clinical Ophthalmology Basel Spinout RhyGaze Closes USD 86 Million Series A Round to Further Novel Gene Therapy for Vision Restoration10.1.2025 15:00:00 EET | Press release
RhyGaze, a biotechnology company based in Basel, Switzerland and Philadelphia, Pa., USA, today announced that it has secured a Series A financing of USD 86 million. The round was led by GV (Google Ventures), alongside Arch Venture Partners, F-Prime Capital and founding investors BioGeneration Ventures and Novartis Venture Fund, who contributed USD 11 million to an earlier seed round. RhyGaze was founded on intellectual property exclusively licensed to the company by the Institute of Molecular and Clinical Ophthalmology Basel (IOB), a scientific institute led by Director Botond Roska, M.D., Ph.D., who is a scientific co-founder of RhyGaze. This funding will enable further development of RhyGaze’s lead clinical candidate, a novel gene therapy for optogenetic vision restoration in diseases causing blindness. Activities to be supported include formal pharmacology and toxicology testing, a non-interventional, observational study to assess potential clinical endpoints in patient groups eligi
Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore10.1.2025 14:30:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced an exclusive collaboration and license agreement for the development and commercialization of Vertex’s povetacicept (pove) in mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore (the licensed territory). Pove is a recombinant fusion protein therapeutic and dual antagonist of BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) with best-in-class potential being studied for the treatment of Immunoglobulin A nephropathy (IgAN) and other B cell-mediated diseases. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250110168811/en/ Under the terms of the agreement, Vertex will receive an upfront payment, as well as certain regulatory milestone payments and tiered royalties, on net sales of pove in the region of focus for Zai Lab. Zai Lab will utilize its extensive research and deve
Compass Pathways Announces Pricing of Underwritten Offering10.1.2025 14:01:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten offering of 24,014,728 American Depositary Shares (“ADSs”) and in lieu of ADS, to certain institutional investors, pre-funded warrants to purchase up to 11,044,720 ADSs. Each ADS and pre-funded warrant shall be accompanied by a warrant (“ADS Warrant”) to purchase one ADS, which has an exercise price of $5.796 per ADS, representing a 40% premium to the last sale price and will be exercisable following a specified data milestone. The offering price is $4.275 per ADS and accompanying ADS Warrant, and $4.2649 per pre-funded warrant and accompanying ADS Warrant. All of the securities are to be sold by Compass. The offering is expected to close on or about January 13, 2025, subject to satisfaction of customary closing conditions. The offering was led by Deep Track Capital and included participation
Ronald S. Lauder to Retire from The Estée Lauder Companies’ Board of Directors10.1.2025 13:45:00 EET | Press release
The Estée Lauder Companies (NYSE: EL) announced today that Ronald S. Lauder will retire from the Company’s Board of Directors (the “Board”) effective immediately. Pursuant to the stockholders’ agreement among Lauder family members and the Company, Mr. Lauder has the right to designate two directors of the Company. His daughter Jane Lauder will continue to serve on the Board in her current position, and he has named his son-in-law Eric Zinterhofer, who is married to his daughter Aerin Lauder, to be his second designee. In connection with Mr. Lauder’s retirement from the Board and his designation of Mr. Zinterhofer as his nominee, the Board has elected Mr. Zinterhofer effective immediately. Mr. Lauder will remain Chairman of Clinique Laboratories, LLC. Mr. Zinterhofer joins the Board with extensive financial, investing and global business experience, and is currently a Founding Partner of Searchlight Capital Partners. He serves on the Investment Committee, Operating Committee and Valuati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom